Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Evaluation of low-dose, low-frequency oral psoralen–UV-A treatment with or without maintenance on early-stage mycosis fungoides: A randomized clinical trial

JAMA | May 13, 2019 Pharmacology/Therapy

Topical combination of fluorouracil and calcipotriene as a palliative therapy for refractory extramammary Paget disease

JAMA | May 13, 2019 Pharmacology/Therapy

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: A single-centre, single-arm, phase 2 trial

The Lancet Oncology | May 13, 2019 Pharmacology/Therapy

Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study

Journal of Clinical Oncology | May 13, 2019 Pharmacology/Therapy

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): A randomised, double-blind, phase 3 trial

The Lancet Oncology | May 12, 2019 Pharmacology/Therapy

Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: An open-label, multicenter, phase III randomized trial

Journal of Clinical Oncology | May 12, 2019 Pharmacology/Therapy

Comparison of population-based observational studies with randomized trials in oncology

Journal of Clinical Oncology | May 12, 2019 Pharmacology/Therapy

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies

European Journal of Haematology | May 12, 2019 Pharmacology/Therapy

Non-curative treatment of patients with oral tongue squamous-cell carcinoma

European Archives of Oto-Rhino-Laryngology | May 12, 2019 Pharmacology/Therapy

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): A phase 3 randomised controlled trial

The Lancet: Gastroenterology & Hepatology | May 12, 2019 Pharmacology/Therapy

« Prev 1 … 207 208 209 210 211 … 375 Next »

Evaluation of low-dose, low-frequency oral psoralen–UV-A treatment with or without maintenance on early-stage mycosis fungoides: A randomized clinical trial

Topical combination of fluorouracil and calcipotriene as a palliative therapy for refractory extramammary Paget disease

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: A single-centre, single-arm, phase 2 trial

Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): A randomised, double-blind, phase 3 trial

Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: An open-label, multicenter, phase III randomized trial

Comparison of population-based observational studies with randomized trials in oncology

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies

Non-curative treatment of patients with oral tongue squamous-cell carcinoma

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): A phase 3 randomised controlled trial

Article on Tirzepatide: Latest Guidelines, Uses, and Clinical Evidence in Obesity and Diabetes Management

MD Clip on How to Assess, Monitor, and Treat Hepatitis B

Article: Cardiovascular Risk in Diabetes: Integrating GLP-1 and SGLT2 Therapy

Understanding your risk: Are women likelier to have thyroid cancer than men are?

Mediterranean diet provides symptom relief for patients with ibs in pilot study

Evaluation of low-dose, low-frequency oral psoralen–UV-A treatment with or without maintenance on early-stage mycosis fungoides: A randomized clinical trial

Topical combination of fluorouracil and calcipotriene as a palliative therapy for refractory extramammary Paget disease

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: A single-centre, single-arm, phase 2 trial

Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): A randomised, double-blind, phase 3 trial

Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: An open-label, multicenter, phase III randomized trial

Comparison of population-based observational studies with randomized trials in oncology

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies

Non-curative treatment of patients with oral tongue squamous-cell carcinoma

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): A phase 3 randomised controlled trial

Article on Tirzepatide: Latest Guidelines, Uses, and Clinical Evidence in Obesity and Diabetes Management

MD Clip on How to Assess, Monitor, and Treat Hepatitis B

Article: Cardiovascular Risk in Diabetes: Integrating GLP-1 and SGLT2 Therapy

Understanding your risk: Are women likelier to have thyroid cancer than men are?

Mediterranean diet provides symptom relief for patients with ibs in pilot study

Select Specialty

Select Topic